Mao, Chen <br/><br/>
BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Aug 2010 
 - 1293-4 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-010-0922-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Colorectal Neoplasms--drug therapy<br/>ErbB Receptors--immunology<br/>Humans<br/>Mutation<br/>Neoplasm Metastasis--genetics<br/>Proto-Oncogene Proteins B-raf--genetics